$15.16 billion is the projected size of the global AI-enabled imaging modalities market by 2035, up from $3.62 billion in 2025.
15.9% annual growth is being driven by rising chronic disease, demand for earlier and more accurate diagnosis, and hospitals' push to automate image analysis and ease radiologist shortages.
Hospitals held the largest share in 2025, while deep-learning tools are forecast to grow fastest because they improve abnormality detection across CT, MRI, X-ray, ultrasound and mammography.
North America led the market in 2025, supported by established healthcare systems, strong AI adoption, funding, and favorable digital-health and reimbursement policies.
GE HealthCare, Siemens Healthineers and Philips were among companies expanding offerings in 2025, even as regulatory approvals, data privacy, cybersecurity and integration costs remain key adoption hurdles.